ELTX
Elicio Therapeutics Inc.
1.80$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | +140.7% | -55.4% | +298.3% | +103.8% | -76.5% | +19.8% | +3.8% | -8.2% | |
| – | +26.9% | +880.7% | -76.2% | +560.3% | +126.3% | -88.3% | +52.5% | +26.6% | -6.7% | |
| – | +46.5% | +1,140.1% | -78.2% | +521.2% | +156.5% | -91.2% | +65.4% | +36.6% | +5.4% | |
| – | +46.5% | +1,140.1% | -78.2% | +521.2% | +156.5% | -91.2% | +65.4% | +36.6% | +5.4% | |
| – | -16.3% | -78.0% | +311.2% | +1,036.4% | -83.9% | – | – | – | – | |
| – | – | – | – | – | – | +2,133.2% | – | – | – | |
| – | – | – | – | -28.3% | -13.4% | +857.5% | – | – | – | |
| – | -2.8% | +16.9% | +294.9% | +352.2% | -89.1% | -8.4% | +14.7% | +150.4% | -38.7% | |
| – | +3.8% | +541.3% | +261.3% | +304.3% | -89.5% | -39.2% | +42.0% | +18.1% | -29.6% | |
| – | +5.7% | – | – | +1,070.8% | -98.8% | -27.3% | +31.5% | -1.0% | +12.2% | |
| – | -82.0% | +1,319.4% | +2,004.7% | -50.4% | -15.6% | -40.4% | +55.8% | -76.2% | -35.3% | |
| – | – | – | – | – | – | – | – | – | -53.0% | |
| – | +37.0% | +707.2% | -198.3% | – | – | -89.1% | +27.6% | -199.5% | – | |
| – | +37.1% | -1,802.8% | – | – | – | – | – | – | – | |
| – | +0.0% | +48,077.3% | +176.4% | +0.0% | -60.7% | -3.1% | +63.1% | +141.3% | +25.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.